News
22 August 2024
Read more
White paper: Development and production of orphan drugs. Tailored solutions by Lab Ofichem
Development and production of orphan drugs. Tailored solutions by Lab Ofichem
12 March 2024
Read more
Whitepaper: Accelerating drug development using 505(b)(2) regulatory pathways
Accelerating drug development using 505(b)(2) regulatory pathways
23 January 2023
Read more
Drug manufacturer InnoGenerics acquired.
Drug manufacturer InnoGenerics acquired by the Ofichem Group.
29 July 2022
Read more
Is the market still growing?
The outlook of CDMO for active pharmaceutical ingredients (APIs): Is the market still growing?
16 May 2022
Read more
Ofidit and Rephine: Partners in Business
The mutually-beneficial alliance will see the deeply-experienced global GMP auditors assume responsibility for Ofidit’s third-party audit service and stock its audit reports in its extensive library
20 July 2021
Read more
Ofipharma/Ofichem secures the Netherlands with extra Propofol supply
Ofipharma and Ofichem have managed to bring in additional stock of Propofol ampoules to the Netherlands. Propofol is an essential anaesthetic in the ventilation of COVID-19 patients.
20 July 2021
Read more
Building of new R&D pilot plant started
Our colleagues in China recently moved in their new office.